161 related articles for article (PubMed ID: 2947366)
1. Pharmacodynamics of cyclosporine.
Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
[No Abstract] [Full Text] [Related]
2. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
Granelli-Piperno A; Keane M
Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
[No Abstract] [Full Text] [Related]
3. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
Hess AD; Colombani PM
Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
[No Abstract] [Full Text] [Related]
4. [Mechanism of action of cyclosporin A].
Wagner H; Hardt C; Heeg K
Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
[No Abstract] [Full Text] [Related]
5. Cyclosporin. Mechanism of action: in vitro studies.
Hess AD; Colombani PM
Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
[No Abstract] [Full Text] [Related]
6. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
Freed BM; Rosano TG; Quick C; Lempert N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
[No Abstract] [Full Text] [Related]
7. Lack of an obligate role for IFN-gamma in the primary in vitro mixed lymphocyte response.
Bucy RP; Hanto DW; Berens E; Schreiber RD
J Immunol; 1988 Feb; 140(4):1148-52. PubMed ID: 2963862
[TBL] [Abstract][Full Text] [Related]
8. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
Fahr A; Hiestand P; Ryffel B
Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
[No Abstract] [Full Text] [Related]
9. Immunosuppressive activity of cyclosporine metabolites in vitro.
Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
[No Abstract] [Full Text] [Related]
10. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes.
Buurman WA; Daemen AJ; van der Linden CJ; Kootstra G
Transplant Proc; 1987 Feb; 19(1 Pt 2):1193. PubMed ID: 3152624
[No Abstract] [Full Text] [Related]
11. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
[No Abstract] [Full Text] [Related]
12. The effects of cyclosporin A on the immune system.
Shevach EM
Annu Rev Immunol; 1985; 3():397-423. PubMed ID: 3933532
[No Abstract] [Full Text] [Related]
13. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
Havele C; Paetkau V
J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.
Freed BM; Stevens C; Zhang G; Rosano TG; Lempert N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):233-9. PubMed ID: 3284070
[No Abstract] [Full Text] [Related]
15. Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
Hess AD; Esa AH; Colombani PM
Transplant Proc; 1988 Apr; 20(2 Suppl 2):29-40. PubMed ID: 2834840
[No Abstract] [Full Text] [Related]
16. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
[No Abstract] [Full Text] [Related]
17. Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production.
Manfro RC; Pohanka E; Tomlanovich S; Benet LZ; Garovoy MR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1457-9. PubMed ID: 2523586
[No Abstract] [Full Text] [Related]
18. Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.
Hess AD; Tutschka PJ; Pu Z; Santos GW
J Immunol; 1982 Jan; 128(1):360-7. PubMed ID: 6459375
[No Abstract] [Full Text] [Related]
19. Mechanism of cyclosporin action: in vitro studies.
Ryffel B
Ann Inst Pasteur Immunol; 1987; 138(4):635-9. PubMed ID: 3499916
[No Abstract] [Full Text] [Related]
20. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
